Baldness by Country: Top 6 Countries Most Affected

Mediterranean Europe tops this rather unwelcome league table. We’re talking about nearly half of all men in these regions developing significant baldness at some point. Meanwhile, certain Asian countries see rates roughly three times lower.

These patterns aren’t coincidental. They’re rooted in genetic variations passed down through generations – something researchers have documented extensively in hereditary baldness studies.

The Top 6 Countries Most Affected by Baldness

No. 1: Spain – 44.50% of Men Affected

Spain claims the top spot globally, with close to 45% of men experiencing androgenetic alopecia. Several factors converge to explain this.

The Spanish population shows high prevalence of genetic variants in the AR (androgen receptor) gene – the key player in follicular sensitivity to DHT. Genomic research reveals that Iberians commonly carry risk alleles linked to earlier and more severe baldness.

The Mediterranean climate plays its part too. Intense sun exposure damages hair follicles that are already genetically vulnerable. Add to this Spain’s historically high smoking rates – one of the highest in Europe – and you’ve got a recipe for hair loss, given that smoking roughly doubles alopecia risk.

No. 2: Italy – 44.37% of Men Affected

Italy sits just 0.13 points behind Spain. Italians share that Mediterranean genetic heritage, with similarly high concentrations of X chromosome risk variants.

What’s particularly interesting about Italy is the regional variation. Southern areas – genetically closer to Greek and Middle Eastern populations – show higher rates. Some local surveys in Sicily and Calabria report figures exceeding 46%.

Italy also leads Europe for hair transplants performed domestically, which speaks volumes about the demand this prevalence creates.

No. 3: France – 44.25% of Men Affected

France rounds out the top three at 44.25%. Roughly one in two French men will experience some degree of baldness during their lifetime – from mild temple recession to more extensive crown loss.

France’s position at the crossroads of Nordic and Mediterranean genetic influences explains these numbers. Southern regions like Provence and Occitanie mirror Spanish rates, whilst northern areas track closer to Germany.

There’s another notable pattern here: France sees some of the earliest average onset ages. Around 25% of French men show visible hair loss before 30, which is why many seek early consultations about preventative options like finasteride or minoxidil.

No. 4: The United States – 42.68% of Men Affected

The US comes in fourth at 42.68% – a figure shaped by America’s genetic diversity, though European ancestry still predominates.

Caucasian Americans show rates comparable to their European counterparts (around 44-45%), whilst African Americans and Asian Americans bring the average down with prevalences of roughly 30% and 20% respectively.

Despite ranking fourth for prevalence, America dominates the global hair restoration market by spending. The country has over 4,000 surgeons performing male hair transplants, generating billions annually.

No. 5: Germany – 41.51% of Men Affected

Germany closes out the top five at 41.51%. German populations show somewhat lower prevalence than their Mediterranean neighbours but remain well above the global average.

Genetic studies suggest Germans carry the most aggressive AR gene risk variants less frequently. The practical upshot? German baldness typically progresses more slowly, reaching advanced Norwood stages around 5 to 7 years later on average than in Spain or Italy.

Germany has also pioneered preventative approaches, adopting treatments early and maintaining one of Europe’s highest finasteride prescription rates.

No. 12: The United Kingdom – 40.09% of Men Affected

Here’s one that surprises many: the UK actually ranks 12th at 40.09%. British men have a reputation for being particularly prone to baldness, but the data tells a different story.

This misconception likely stems from media visibility – British celebrities tend to be more open about hair loss than their counterparts elsewhere, creating an impression of higher prevalence. In reality, we’re squarely in line with the European average.

The genetic blend of Celtic, Saxon, and Nordic influences produces an intermediate profile. Scotland and Ireland show slightly lower rates (around 38%), whilst the South East of England edges closer to 42%.

The Complete Ranking: 47 Countries Analysed

The contrast is remarkable: Spain to Indonesia represents nearly 18 percentage points. Statistically, a Spanish man is almost twice as likely to lose his hair as an Indonesian man.

Why Are Caucasians Five Times More Affected?

This is the question everyone asks. The answer lies primarily in our genetics.

International comparative research establishes a clear ethnic hierarchy, with Caucasians significantly ahead. One major study analysing 26,340 photographs of Caucasian men aged 30 to 40 across 19 countries found severe alopecia (Norwood stage VI-VII) in roughly 15% on average. Among men of Israeli Jewish origin, that figure approaches 20%.

Asian populations present a completely different picture. A Chinese study of 7,056 subjects established male prevalence at just 19.9%. Japanese and Korean men show similar rates – between 14% and 20% depending on age.

Age of onset varies by ethnicity too

It’s not just about how many men are affected – timing differs by roughly a decade. Caucasian men typically notice their first signs around 25-30, whilst Asian men more commonly see changes around 35-40. This has real implications for determining the ideal timing for a hair transplant.

A Korean study from Kyung Hee, covering over 10,000 participants, illustrates this clearly: just 2.3% of Koreans are affected between ages 20 and 29, compared to 25-30% of Caucasians in the same bracket. The gap narrows somewhat after 70 – roughly 47% of Koreans versus 80% of Caucasians.

The AR gene: the main culprit

Genetics accounts for approximately 80% of baldness predisposition, making it one of dermatology’s most heritable conditions. Central to this is the androgen receptor (AR) gene on the X chromosome.

This single gene explains 46% of the genetic risk for androgenetic alopecia. Its X chromosome location also clarifies why maternal inheritance matters so much: men inherit their X chromosome from their mother, so your maternal grandfather’s hair history often predicts your own.

Researchers have now identified over 600 genetic polymorphisms across more than 350 genomic regions, all contributing to baldness risk in varying degrees. The frequency of these variants differs substantially between ancestral populations.

Caucasian Europeans carry AR gene risk alleles more commonly, explaining their higher prevalence. The mechanism is well understood: DHT (dihydrotestosterone) binds to receptors encoded by this gene, causing progressive follicle miniaturisation. This follows predictable patterns documented by the Norwood-Hamilton scale for men and the Ludwig scale for women.

Environmental factors that accelerate things

Genetics dominates, but it doesn’t tell the whole story. Certain environmental factors significantly speed up baldness progression, regardless of geography.

Smoking tops the list. A recent meta-analysis shows smokers face 1.8 times greater risk of androgenetic alopecia. Ten or more cigarettes daily more than doubles this risk. The mechanisms? Oxidative stress damages follicles directly, whilst vasoconstriction reduces scalp blood flow.

Chronic stress is another well-documented accelerator, capable of triggering or speeding up hair loss in predisposed individuals by disrupting the natural growth cycle.

Diet plays a role too. High intake of saturated fats and refined sugars correlates with increased prevalence. Deficiencies in vitamins B12 and D, iron, zinc, and biotin can worsen existing hair loss – which is where appropriate dietary supplements come in. These factors don’t cause baldness outright, but they can accelerate it in those already predisposed.

703,000 Hair Transplants Performed Worldwide Each Year

Given these figures, the booming hair restoration market makes perfect sense. The International Society of Hair Restoration Surgery (ISHRS) recorded 703,183 surgical procedures globally in 2021 – a 152% increase since 2010.

The geographical breakdown is telling: Asia-Pacific leads with over 256,000 procedures annually, followed by the Middle East/Africa (124,000), Europe (113,000), and North America (149,000). Turkey has emerged as the world’s leading destination, combining surgical expertise with competitive pricing.

Another striking trend: 95% of new surgical patients are between 20 and 35, according to 2024 ISHRS data. Demand for early treatment keeps rising, driven by better information and growing social acceptance of hair transplantation. The before-and-after results speak for themselves.

Dr Cinik’s Expertise for UK and International Patients

With the UK ranking among Europe’s top countries for hair loss, British patients make up a significant proportion of international consultations for procedures like a hair transplant in Turkey. Dr Emrah Cinik’s clinic regularly welcomes patients from the UK, Ireland, Australia, and across the Commonwealth seeking the most advanced techniques available.

With over 20 years’ experience and thousands of procedures performed, Dr Cinik offers protocols tailored to each patient’s genetic profile and stage of alopecia progression. Sapphire FUE and DHI techniques deliver natural, long-lasting results with optimised healing. The classic FUE technique remains a proven option for many cases too.

PRP, included in all packages, stimulates existing follicles and optimises graft survival. Women affected by female pattern baldness can also access specific protocols designed for their needs.

A free consultation allows us to assess your situation, determine the number of grafts required, and establish a realistic treatment plan. Our medical team monitors your progress closely, month by month, following your procedure.

Because whilst statistics paint one picture, what truly matters is your individual situation and your goals.

Scientific References

Avital, Y. S., Morvillo, V., Paus, R., & Zvulunov, A. (2015). Racial characteristics of male androgenetic alopecia: Prevalence and pattern distribution of male pattern hair loss in 19 countries. International Journal of Dermatology, 54(8), 927-932. https://pubmed.ncbi.nlm.nih.gov/26288425/

Bas, Y., Seckin, H. Y., Kalkan, G., Takci, Z., Citil, R., Onder, Y., & Demir, A. K. (2017). Prevalence and related factors of androgenetic alopecia in men. Northern Clinics of Istanbul, 4(1), 35-40. https://pmc.ncbi.nlm.nih.gov/articles/PMC5312176/

Gupta, A. K., Bamimore, M. A., & Foley, K. A. (2025). The epidemiology of androgenetic alopecia: A systematic review and meta-analysis. PLOS ONE, 20(1), e0319040. https://pubmed.ncbi.nlm.nih.gov/40014580/

Krupa Shankar, D. S., Chakravarthi, M., & Shilpakar, R. (2009). Male androgenetic alopecia: population-based study in 1,005 subjects. International Journal of Trichology, 1(2), 131-133. https://pubmed.ncbi.nlm.nih.gov/20927235/

Paik, J. H., Yoon, J. B., Sim, W. Y., Kim, B. S., & Kim, N. I. (2001). The prevalence and types of androgenetic alopecia in Korean men and women. British Journal of Dermatology, 145(1), 95-99. https://pubmed.ncbi.nlm.nih.gov/11453914/

Severi, G., Sinclair, R., Hopper, J. L., English, D. R., McCredie, M. R., Boyle, P., & Giles, G. G. (2003). Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. British Journal of Dermatology, 149(6), 1207-1213. https://pubmed.ncbi.nlm.nih.gov/14674898/

Wang, T. L., Zhou, C., Shen, Y. W., Wang, X. Y., Ding, X. L., Tian, S., … & Zhang, J. (2010). Prevalence of androgenetic alopecia in China: a community-based study in six cities. British Journal of Dermatology, 162(4), 843-847. https://pubmed.ncbi.nlm.nih.gov/19016703/

International Society of Hair Restoration Surgery. (2022). 2022 Practice Census Results. ISHRS. https://ishrs.org/